Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TC BIOPHARM (HOLDINGS) PLC

(TCBP)
  Report
End-of-day quote Nasdaq  -  2023-01-22
4.770 USD   +3.92%
01/26HC Wainwright Starts TC Biopharm (Holdings) at Buy With $9 Price Target
MT
01/23TC BioPharm to Host Shareholder Update Call
AQ
01/18Top Premarket Gainers
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Weakening Near Monday Close

11/28/2022 | 04:02pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIOGEN INC. -0.63% 290.08 Delayed Quote.4.75%
CINC CORP. -0.47% 1055 Delayed Quote.1.83%
CINCOR PHARMA, INC. 0.03% 28.8 Delayed Quote.134.34%
STANDARD BIOTOOLS INC. 7.04% 2.13 Delayed Quote.82.05%
TC BIOPHARM (HOLDINGS) PLC 3.92% 4.77 End-of-day quote.23.90%
All news about TC BIOPHARM (HOLDINGS) PLC
01/26HC Wainwright Starts TC Biopharm (Holdings) at Buy With $9 Price Target
MT
01/23TC BioPharm to Host Shareholder Update Call
AQ
01/18Top Premarket Gainers
MT
01/17TC Biopharm Plc Announces Strategic Collaboration to Advance Gamma Delta T Cells in Onc..
CI
2022China Reopening Prospects Lend Some Support to European Equities But Uncertain Outlook ..
MT
2022Tc Biopharm : INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - For..
PU
2022TC Biopharm Plc Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022TC BioPharm Announces Closing of $7.35 Million Private Placement
AQ
2022TC BioPharm Raises $7.4 Million in Private Placement
MT
2022Tc Biopharm : Securities Purchase Agreement - Form 6-K
PU
More news
Analyst Recommendations on TC BIOPHARM (HOLDINGS) PLC
More recommendations
Financials (USD)
Sales 2022 2,45 M - -
Net income 2022 -12,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,34x
Yield 2022 -
Capitalization 11,6 M 11,6 M -
Capi. / Sales 2022 4,72x
Capi. / Sales 2023 4,72x
Nbr of Employees 76
Free-Float 93,7%
Chart TC BIOPHARM (HOLDINGS) PLC
Duration : Period :
TC Biopharm (Holdings) Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TC BIOPHARM (HOLDINGS) PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 5,10 $
Average target price 9,00 $
Spread / Average Target 76,5%
EPS Revisions
Managers and Directors
Bryan Kobel Chief Executive Officer & Director
Martin Edward Thorp Chief Financial Officer & Director
Michael Leek Executive Chairman
Angela Scott Chief Operating Officer
Mark L. Bonyhadi Independent Director
Sector and Competitors
1st jan.Capi. (M$)
TC BIOPHARM (HOLDINGS) PLC23.90%12
MODERNA, INC.5.42%72 745
LONZA GROUP AG17.24%42 787
IQVIA HOLDINGS INC.12.00%42 622
ALNYLAM PHARMACEUTICALS, INC.-2.64%28 465
SEAGEN INC.9.46%26 117